APA (7th ed.) Citation

JH, B., PS, J., AD, H., BL, C., AS, D., CSP, L., . . . JJV, M. (2025). Finerenone, chronic obstructive pulmonary disease, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial. European journal of heart failure, 27(8), 1444. https://doi.org/10.1002/ejhf.3661

Chicago Style (17th ed.) Citation

JH, Butt, et al. "Finerenone, Chronic Obstructive Pulmonary Disease, and Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial." European Journal of Heart Failure 27, no. 8 (2025): 1444. https://doi.org/10.1002/ejhf.3661.

MLA (9th ed.) Citation

JH, Butt, et al. "Finerenone, Chronic Obstructive Pulmonary Disease, and Heart Failure with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the FINEARTS-HF Trial." European Journal of Heart Failure, vol. 27, no. 8, 2025, p. 1444, https://doi.org/10.1002/ejhf.3661.